The protein size, electrical interaction, and conformational stability of etanercept (marketed as Enbrel ® ) were examined by thermodynamic and light scattering methods with changing pH and buffer concentration. As pH of etanercept increased from pH 6.6 to 8.6, electrical repulsion in the solution increased, inducing a decrease in protein size. However, the size changed less in high buffer concentration and irreversible aggregation issues were not observed; in contrast, aggregates of about 1000 nm were observed in low buffer concentration at the pH range. Three significant unfolding transitions (T m ) were observed by differential scanning calorimetry (DSC). Unlikely to T m 1, T m 2 and T m 3 were increased as the pH increased. Higher T m at high buffer concentration was observed, indicating increased conformational stability. The apparent activation energy of unfolding was further investigated since continuous increase of T m 2 and T m 3 was not sufficient to determine optimal conditions. A higher energy barrier was calculated at T m 2 than at T m 3. In addition, the energy barriers were the highest at pH from 7.4 to 7.8 where higher T m 1 was also observed. Therefore, the conformational stability of protein solution significantly changed with pH dependent steric repulsion of neighboring protein molecules. An optimized pH range was obtained that satisfied the stability of all three domains. Electrostatic circumstances and structural interactions resulted in irreversible aggregation at low buffer concentrations and were suppressed by increasing the concentration. Therefore, increased buffer concentration is recommended during protein formulation development, even in the earlier stages of investigation, to avoid protein instability issues.Key words buffer concentration; etanercept; differential scanning calorimetry (DSC); dynamic light scattering (DLS); pH effect; scan rate effect Advances in biotechnology in the last decades have made it possible to produce a number of proteins for therapeutic uses. Protein pharmaceuticals have drawn a lot of attention by virtue of their effectiveness and patient needs. Consequently, therapeutic proteins have overtaken low molecular weight compounds as the objects of novel drug development in the last decade.1,2) However, these proteins have complicated structures, marginal stability, and high sensitivity to degradation. Moreover, the proteins must be stabilized in solution to maintain their efficacy and benefits.
3-6)Protein aggregates are problematic because of possible activity loss and immunogenicity issues.7,8) Therefore, it is important to determine the causes of protein aggregation in order to minimize it to an acceptable level. Mutual interactions between pH and various buffers with lysozyme were investigated using a robust design (RD) method in a previous study.9) Acceptable pH range and buffer were selected based on thermodynamic properties from differential scanning calorimetry (DSC). In addition, selection of suitable buffer system of human epithelial growth factor b...